Skip to main content
. Author manuscript; available in PMC: 2016 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):463–471. doi: 10.1097/QAI.0000000000000802

Table 3.

α4β7 tripeptide mimotope distribution among worldwide HIV-1 V2 sequences retrieved from the Los Alamos HIV Sequence Database

SUBTYPE TRIPEPTIDE TOTAL SEQS %
FORMER USSR
A/A1 (145)* LDI 141 97.2
LDV 1 0.7
others 3 2.1
B (24) LDI 7 29.2
LDV 7 292
others 10 41.7

SOUTHEAST ASIA
CRF01_AE (465) LDI 357 76.8
LDV 8 1.7
others 100 21.5
B (43) LDI 6 14
LDV 24 55.8
others 13 30.2

CHINA
CRF01_AE (282) LDI 196 69.5
LDV 8 2.8
others 78 27.7
CRF07_BC (341) LDI 321 94.1
LDV 13 3.8
others 7 2.1
CRF08_BC (62) LDI 52 83.9
LDV 1 1.6
others 9 14.5
B (229) LDI 103 45
LDV 79 34.4
others 47 20.5

SOUTH AFRICA
C (744) LDI 311 41.8
LDV 48 6.4
others 385 51.8
A/A1 (4) LDI 0 0
LDV 3 75
others 1 25
B (13) LDI 3 23.1
LDV 8 61.5
others 2 15.4

WESTERN AFRICA
CRF02_AG (80) LDI 11 13.8
LDV 39 48.8
others 30 37.5

EAST AFRICA
A/A1 (303) LDI 125 41.2
LDV 146 48.2
others 32 10.6
C (93) LDI 62 66.7
LDV 15 16.1
others 16 17.2
D (40) LDI 3 7.5
LDV 31 77.5
others 6 15

CENTRAL AFRICA
CRF02_AG (56) LDI 7 12.5
LDV 21 37.5
others 28 50
CRF11_cpx (30) LDI 13 43.3
LDV 14 46.7
others 3 10
*

Numbers in parentheses refer to the number of sequences analyzed for each given HIV subtype and location.